US company Vertex called out in funding battle for cystic fibrosis drug Trikafta | Newshub

Trikafta. It's the $430,000-a-year drug that changed Bella Powell's life. She has cystic fibrosis and is calling out the drug's US manufacturer as Kiwis fight for access. This is the first of a three-part investigation from Patrick Gower. ➡️ SUBSCRIBE: bit.ly/3kQM2OS​
See more: www.newshub.co...
You're joining us on the official KZbin channel for Discovery NZ's Newshub. Here you will find livestreams and news videos from our award-winning team of journalists working across our bulletins and shows - The Project NZ, The AM Show and Newshub Nation.
Like Newshub on Facebook: bit.ly/2SOOIR3​
Follow Newshub on Twitter: bit.ly/33Vru29​
Sign up for the Newshub Now newsletter: bit.ly/33S4fWp​
Follow Newshub on Instagram: bit.ly/2KUlxWW
For all footage l​​icencing enquiries please visit: www.discoveryc...